发明名称 |
FORMULATIONS OF TOCOTRIENOL QUINONES FOR TREATMENT OF OPHTHALMIC DISEASES |
摘要 |
PROBLEM TO BE SOLVED: To provide formulations of tocotrienol quinones for treatment of ophthalmic diseases.SOLUTION: A formulation is disclosed comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone. Also discussed is the use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder. Also discussed is a method of treating or controlling ocular symptoms associated with neurodegenerative diseases or traumas with a formulation comprising one or more tocotrienol quinones. Also discussed is a method of treating or controlling ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones.SELECTED DRAWING: None |
申请公布号 |
JP2016128523(A) |
申请公布日期 |
2016.07.14 |
申请号 |
JP20160078793 |
申请日期 |
2016.04.11 |
申请人 |
EDISON PHARMACEUTICALS INC |
发明人 |
MILLER GUY M;WILLIAM D SHRADER;VIKTORIA KHEIFETS |
分类号 |
A61K31/122;A61K9/08;A61P3/10;A61P7/10;A61P9/00;A61P9/10;A61P21/02;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/28;A61P27/02;A61P27/06;A61P43/00 |
主分类号 |
A61K31/122 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|